Evidence map›Paper›PMID 38725050›Full record

ArticleJournal of anesthesia, analgesia and critical care2024

Long-term outcome of COVID-19 patients with acute kidney injury requiring kidney replacement therapy.

Ilaria Godi, Laura Pasin, Andrea Ballin, Gabriele Martelli, Claudio Bonanno, Francesco Terranova, Enrico Tamburini, Caterina Simoni, Ginevra Randon, Nicola Franchetti and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of anesthesia, analgesia and critical care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ilaria GodiDepartment of Urgency and Emergency, Anaesthesiology and Intensive Care Unit, University Hospital of Padua, Via Giustiniani 2, Padua, Italy. Ilaria.g88@libero.it.ORCID http://orcid.org/0000-0001-8387-5176
Laura PasinDepartment of Urgency and Emergency, Anaesthesiology and Intensive Care Unit, University Hospital of Padua, Via Giustiniani 2, Padua, Italy.
Andrea BallinDepartment of Urgency and Emergency, Anaesthesiology and Intensive Care Unit, University Hospital of Padua, Via Giustiniani 2, Padua, Italy.
Gabriele MartelliDepartment of Urgency and Emergency, Anaesthesiology and Intensive Care Unit, University Hospital of Padua, Via Giustiniani 2, Padua, Italy.
Claudio BonannoDepartment of Urgency and Emergency, Anaesthesiology and Intensive Care Unit, University Hospital of Padua, Via Giustiniani 2, Padua, Italy.
Francesco TerranovaDepartment of Urgency and Emergency, Anaesthesiology and Intensive Care Unit, University Hospital of Padua, Via Giustiniani 2, Padua, Italy.
Enrico TamburiniDepartment of Medicine, Section of Anesthesiology and Critical Care, University of Padua, Padua, Italy.
Caterina SimoniDepartment of Medicine, Section of Anesthesiology and Critical Care, University of Padua, Padua, Italy.
Ginevra RandonDepartment of Medicine, Section of Anesthesiology and Critical Care, University of Padua, Padua, Italy.
Nicola FranchettiDepartment of Medicine, Section of Anesthesiology and Critical Care, University of Padua, Padua, Italy.
Leda CattarinDepartment of Nephrology and Dialysis, University Hospital of Padua, Padua, Italy.
Federico NalessoDepartment of Nephrology and Dialysis, University Hospital of Padua, Padua, Italy.
Lorenzo CalòDepartment of Nephrology and Dialysis, University Hospital of Padua, Padua, Italy.
Ivo TiberioDepartment of Urgency and Emergency, Anaesthesiology and Intensive Care Unit, University Hospital of Padua, Via Giustiniani 2, Padua, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLimited data existed on the burden of coronavirus disease 2019 (COVID-19) renal complications and the outcomes of the most critical patients who required kidney replacement therapy (KRT) during intensive care unit (ICU) stay. We aimed to describe mortality and renal function at 90 days in patients admitted for COVID-19 and KRT.

methodsA retrospective cohort study of critically ill patients admitted for COVID-19 and requiring KRT from March 2020 to January 2022 was conducted in an Italian ICU from a tertiary care hospital. Primary outcome was mortality at 90 days and secondary outcome was kidney function at 90 days.

resultsA cohort of 45 patients was analyzed. Mortality was 60% during ICU stay and increased from 64% at the time of hospital discharge to 71% at 90 days. Among 90-day survivors, 31% required dialysis, 38% recovered incompletely, and 31% completely recovered renal function. The probability of being alive and dialysis-free at 3 months was 22%.

conclusionsCritically ill patients with COVID-19 disease requiring KRT during ICU stay had elevated mortality rate at 90 days, with low probability of being alive and dialysis-free at 3 months. However, a non-negligible number of patients completely recovered renal function.

Indexed as

Acute kidney injuryCOVID-19Kidney recoveryKidney replacement therapyMortality

Identifiers

PMID38725050
PMCPMC11083751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.